Development of Biomarkers for Monitoring Menopause in Women

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This cross-sectional study aims to develop and validate mitochondrial biomarkers for monitoring menopause in women. The study will involve 100 participants divided into three groups: reproductive period, perimenopausal transition period, and postmenopausal period. Peripheral blood samples will be collected, and mitochondrial quality and quantity will be assessed using both qualitative and quantitative analyses. The study will identify potential biomarkers through metabolomics and validate them for monitoring the perimenopausal transition, providing a novel approach for women's health management during menopause.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Healthy Volunteers: t
View:

• Biological female, age order than 20 years old.

Locations
Other Locations
Taiwan
Fu Jen Catholic University Hospital, Fu Jen Catholic University
RECRUITING
New Taipei City
Contact Information
Primary
Shu-Yu Liu
syliu0123@outlook.com
+886910893512
Time Frame
Start Date: 2024-07-30
Estimated Completion Date: 2026-08
Participants
Target number of participants: 100
Treatments
Reproductive Period
Women aged 20-40 years with regular menstrual cycles, representing the reproductive stage.
Perimenopausal Transition Period
Women aged 40-55 years have menstrual cycle within one year but experiencing menstrual irregularities, representing the transition into menopause.
Postmenopausal Period
Women aged 50 years and older who have not had a menstrual period for at least one year, representing the postmenopausal stage.
Related Therapeutic Areas
Sponsors
Leads: Fu Jen Catholic University Hospital

This content was sourced from clinicaltrials.gov